NCM Boston
NCM Boston
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Sebastian B. Teitz
)
- Job title
- Institution
- veryTeitz Consulting, Germany
- Biography
Sebastian has been serving the industry in the field of ‘virus safety of biopharmaceuticals’ for almost two decades. After obtaining his PhD, he became project manager of virus clearance studies at Charles River Laboratories in Cologne, Germany. This was followed by an assignment at AsahiKasei Bioprocess, liaising with industry associations, CROs, and authorities as well as supporting internal and external entities in scientific matters. As a consultant, Sebastian serves drug developers in scientific and regulatory affairs during all stages to market.
- Recent publications
Armstrong, A. et al. Seven Key Takeaways from PDA’s Viral Safety for ATMPs Workshop and Virus Conference Events. PDA Letter.
pda.org/pda-letter-portal/home/full-article/seven-keytakeaways-from-pda-s-viral-safety-for-atmps-workshop-and-virus-conference-events (2023)
[Accessed: 25 July 2024]Koenigsberg, A.L. et al. MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing Facility. PDA J Pharm Sci Technol. 77(2):115–132 (2023).
DOI: 10.5731/pdajpst.2021.012691Yue, C. et al. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products. Viruses. 11(3):234 (2019).
DOI: 10.3390/v11030234
